Monroe Capital Closes on $4.8 Billion of Direct Lending Funds
CHICAGO–(BUSINESS WIRE)–Monroe Capital LLC (“Monroe”) today announced the final close of its 2022 Monroe Capital…
CHICAGO–(BUSINESS WIRE)–Monroe Capital LLC (“Monroe”) today announced the final close of its 2022 Monroe Capital…
NEW YORK–(BUSINESS WIRE)–Spotify Technology S.A. (NYSE:SPOT): Dear Shareholders, Our business exhibited strength and resiliency in…
Aryaka’s SD-WAN and SASE Technology Provides SoftBank Corp. with High-Speed Data Communications, Enabling a Flexible…
VMware Sovereign Cloud Initiative Grows to 14 partners VMware Launches New App Modernization and Data…
1,168 Siemens sites in 94 countries now successfully migrated to SD-WAN as part of its…
BOSTON & LONDON & SINGAPORE–(BUSINESS WIRE)–MassMutual Ventures (MMV) announced today that its Asia-Pacific (APAC) and…
Positioned Highest for “Completeness of Vision” and “Ability to Execute” in 2022 NTT recognized as…
NEW YORK–(BUSINESS WIRE)–Aqara, a leading provider of smart home products, announced the launch of its…
PARIS & AUSTIN, Texas–(BUSINESS WIRE)–Regulatory News: TotalEnergies (Paris:TTE) (LSE:TTE) (NYSE:TTE) is further expanding its presence…
Financial Highlights: Q122 consolidated revenue US$210.72 million, compared with US$153.11 million in the year-ago quarter…
Möglingen, Germany – April 27, 2022 – A global cloud-based services company serving the automotive…
Berlin-based B2B SaaS start-up expands its market position among SMEs and successfully closes financing round…
Nearly two thirds (65%) of IT leaders globally think they need to invest in data…
Juniper Networks, a leader in secure, AI-driven networks, has awarded Nuvias with Distribution Partner of…
Cellectis is developing custom TALEN® for Cytovia to develop gene-edited iPSC-derived Natural Killer cells Cytovia…
AviadoBio’s Gene Therapy Candidate Receives Orphan Designation from Food and Drug Administration and European Commission…
PRESS RELEASE April 27, 2022 Saniona (OMX: SANION), a clinical–stage biopharmaceutical company focused on rare…
OK-101 ameliorates neuropathic corneal pain in a mouse model of ciliary nerve ligation BAM8-22 peptide…
Oslo, Norway, 27th of April 2022 Vistin Pharma ASA (Vistin Pharma, OSE: VISTIN) today announces…
Basel, Switzerland, April 27, 2022 Basilea Pharmaceutica Ltd. (SIX: BSLN), a commercial-stage biopharmaceutical company committed…